July 2004, Volume 34 Number 7 , p 26 - 26
© 2004 Lippincott Williams & Wilkins, Inc. Volume 34(7) July 2004 p 26 New drugs in the marketplace [DRUG NEWS]
These drugs were recently approved by the FDA:
* apomorphine HCl (Apokyn) for patients with Parkinson's disease who develop hypomobility. After 3 to 5 years of treatment with standard Parkinson's drugs, about 10% of patients experience episodes of being unable to speak or walk, known as hypomobility. Apokyn, which is injected, can cause severe nausea and must be taken with an antiemetic.
* fluticasone propionate and salmeterol 100/50 mcg inhalation powder (Advair Diskus) for childhood asthma. Available since 2001 for people ages 12 and older, Advair is now approved for use in children ages 4 to 11 years old with asthma that's symptomatic despite corticosteroid therapy. Because Advair contains both an inhaled corticosteroid and a long-acting ...